Tibremciclib Tartrate
Tier C — Watch / tradeTibremciclib Tartrate
Targets：CDK6, CDK4
Indications (approved)：Breast cancer, Metastatic breast cancer
Regional status
Synthetic routes & intermediates1 routes
Routes are ordered originator first, then optimised / process (non-patent) routes; each lists steps, overall yield and the intermediate table (code / CAS / name) — ready for supplier sourcing and RFQ. Rendered by this site from structured data; no third-party route graphics used.
| Code | CAS No. | Intermediate |
|---|---|---|
| Tibremciclib-001 | 2867-59-6 | (R)-3-aminobutan-1-ol |
| Tibremciclib-002 | 866395-21-3 | benzyl (R)-(4-hydroxybutan-2-yl)carbamate |
| Tibremciclib-003 | - | benzyl (R)-(4-oxobutan-2-yl)carbamate |
| Tibremciclib-004 | 5927-18-4Available | methyl 2-(dimethoxyphosphoryl)acetate |
| Tibremciclib-005 | - | methyl (R,E)-5-(((benzyloxy)carbonyl)amino)hex-2-enoate |
| Tibremciclib-006 | 68330-73-4 | (R)-6-methylpiperidin-2-one |
Frequently asked questions
What are the approved indications of Tibremciclib Tartrate?
Approved indications include: Breast cancer, Metastatic breast cancer.
When does the Tibremciclib Tartrate patent expire?
No public expiry year is available for Tibremciclib Tartrate yet; this page updates once verified.
How many synthesis routes are recorded for Tibremciclib Tartrate?
1 synthesis routes are recorded; the shortest is 4 steps with 1.92 g total yield. Intermediates in each route carry codes and CAS numbers.
Where can I buy Tibremciclib Tartrate intermediates?
1 intermediate CAS of Tibremciclib Tartrate are available through the Unibest supply network — see the route tables on this page and request a quote per CAS.
How do I get a quote for Tibremciclib Tartrate intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-10-22